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Cohen syndrome is an uncommon autosomal recessive disorder whose diagnosis is based on the clinical picture of
nonprogressive psychomotor retardation and microcephaly, characteristic facial features, retinal dystrophy, and
intermittent neutropenia. We have refined the critical region on chromosome 8q22 by haplotype analysis, and we
report the characterization of a novel gene, COH1, that is mutated in patients with Cohen syndrome. The longest
transcript (14,093 bp) is widely expressed and is transcribed from 62 exons that span a genomic region of ∼864
kb. COH1 encodes a putative transmembrane protein of 4,022 amino acids, with a complex domain structure.
Homology to the Saccharomyces cerevisiae VPS13 protein suggests a role for COH1 in vesicle-mediated sorting
and transport of proteins within the cell.
Introduction
Cohen syndrome (MIM 216550) (Cohen et al. 1973;
Carey and Hall 1978) is one of the rare autosomal re-
cessive disorders that are overrepresented in the Finnish
population (Norio 2003). The phenotype in the Finnish
patients is highly homogeneous, consisting of nonpro-
gressive mild-to-severe psychomotor retardation, motor
clumsiness, microcephaly, characteristic facial features,
childhood hypotonia and joint laxity, a progressive re-
tinochoroidal dystrophy, myopia, intermittent isolated
neutropenia, and a cheerful disposition (Norio et al. 1984;
Kivitie-Kallio and Norio 2001). The characteristic facial
features include high-arched or wave-shaped eyelids, a
short philtrum, thick hair, and low hairline (fig. 1). The
ophthalmological features have been described elsewhere
in detail (Kivitie-Kallio et al. 2000); however, in a pleio-
tropic syndrome like this, it is not possible to determine
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a minimum number of features required for the diagnosis
(Norio et al. 1984; Kivitie-Kallio and Norio 2001).
In non-Finnish patients who are said to have Cohen
syndrome, a confusing phenotypic variability prevails.
A multitude of different features have been combined
with this diagnosis in different patients. Obesity, al-
though frequently mentioned as a characteristic finding,
is insignificant. On the other hand, there is no proof of
retinochoroidal dystrophy or intermittent neutropenia
in reports of several patients. Thus, a distinct clinical—
and possibly also genetic—heterogeneity prevails among
the patients with Cohen syndrome presented in the lit-
erature (Kondo et al. 1990; Kivitie-Kallio and Norio
2001; Chandler and Clayton-Smith 2002).
In studies published elsewhere, we assigned the
COH1 locus for Cohen syndrome to an ∼0.6-cM re-
gion, close to marker locus D8S1762 on chromosome
8q22, by use of linkage disequilibrium and haplotype
analysis in Finnish families (Tahvanainen et al. 1994;
Kolehmainen et al. 1997). In the present study, further
haplotype analysis was used to refine the COH1 critical
region, allowing the identification and characterization
of a novel gene, COH1, that is mutated in patients with
Cohen syndrome. It encodes a protein of 4,022 amino
acids (aa), of unknown function, whose domain struc-
ture and homologies suggest an involvement in vesicle-
mediated sorting and intracellular protein transport.
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Figure 1 Characteristic facial features in patients with Cohen syndrome. A, A 12-year-old girl. B, A 21-year-old man. Both patients are
Finnish and are homozygous for the c.3348_3349delCT mutation.
Subjects and Methods
Families with Cohen Syndrome and Control Samples
Blood samples were obtained from 27 Finnish patients
with Cohen syndrome (patients 1–27) in 20 families and
from 43 healthy family members. Part of each blood
sample was used for DNA extraction, and part was used
to establish a lymphoblastoid cell line for subsequent
DNA and RNA extraction. Two patients with Cohen
syndrome (patients 28 and 29) from the UnitedKingdom
(Chandler et al. 2003), two (patients 30 and 31) from
Belgium (Fryns et al. 1996), and one (patient 32) from
Denmark, all of northern European descent, were also
included in the study. All patients included in the study
had the classical Cohen syndrome phenotype and ful-
filled the essential diagnostic criteria for Cohen syn-
drome, including developmental delay, microcephaly,
characteristic facial dysmorphism (fig. 1), retinocho-
roidal dystrophy, and neutropenia. All but three of the
Finnish patients were included in a clinical study re-
ported elsewhere (Kivitie-Kallio and Norio 2001), in
which their features are described thoroughly. Control
DNA samples from 58 anonymous Finnish blood donors
were obtained from the Finnish Red Cross Blood Trans-
fusion Service. DNA samples from 94 grandparents of
the CEPH reference families were also used as controls.
The study has been reviewed and approved by the ethical
review board of the Department of Medical Genetics at
the University of Helsinki.
Computational Analyses and Sequence Annotation
Sequence comparisons were performed using BLAST
(Altschul et al. 1997) and Align (Southampton Bio-
Informatics Data Server; Pearson and Lipman 1988).
Prosite (Hofmann et al. 1999) and ProDom (Gouzy
et al. 1999) were accessed via the ExPASy Molecular
Biology Server. Kyte-Doolittle hydrophobicity profile
(Kyte and Doolittle 1982) was analyzed with an acces-
sory application in the BioEdit sequence alignment ed-
itor. The secondary structure predictionswere performed
using SOPMA (Poˆle Bio-Informatique Lyonnais; Geour-
jon and Deleage 1995). PSORT II (ExPASy Molecular
Biology Server; Nakai and Kanehisa 1992) was used in
the subcellular localization prediction of the protein.
Transmembrane topology prediction was performed us-
ing TMAP (Persson and Argos 1994). BioEdit accessory
application programs CAP3 (Huang and Madan 1999)
and Clustal W (Thompson et al. 1994) were used in DNA
and protein sequence alignment, respectively.
Identification of the COH1 Gene
Continuous partial transcript sequences were assem-
bled in silico. Predicted exons and noncontinuous single
EST sequences were linked to the in silico assembled
sequences by RT-PCR on lymphoblastoid cell total
RNA. The total assembled gene sequence was verified
in overlapping fragments. RNA was isolated using
TRIZOL (Life Technologies) and the RNeasy Mini Kit
(Qiagen), according to the suppliers’ instructions. RT-
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Figure 2 Positional identification of the COH1 gene. A, Haplotypes in 40 COH1 chromosomes from one patient in each of 20 Finnish
families with Cohen syndrome. Twelve markers covering the 2.2-Mb COH1 critical region were used. Italic type indicates the five microsatellite
markers published elsewhere. Marker CA-CEN1 is within intron 33 of COH1. Haplotypes associated with the c.3348_3349delCT mutation
are boxed. Historical recombinations refine the COH1 region to between D8S257 and D8S559. Nondefined alleles are marked with “N.” B,
The COH1 critical interval. Shown are the positions of three polymorphic markers, known genes analyzed for mutations in patients with Cohen
syndrome (represented as arrows in the direction of transcription), and the COH1 transcript (assembled using in silico homology searches,
exon predictions, and RT-PCR); the direction of transcription is indicated (arrowhead).
PCR was performed as described elsewhere (Joensuu et
al. 2001).
Mutation Analysis
COH1 was sequenced for mutations in 10 Finnish
patients representing different haplotypes and in the five
non-Finnish patients. Mutations were identified using
either direct sequencing from lymphoblastoid cell RNA
after RT-PCR (nine patients) in 27 overlapping frag-
ments or were identified exon by exon (six patients),
using direct sequencing or SSCP analysis of genomic
DNA (primers available on request). The identified
changes were analyzed in all available patients and fam-
ily members and in control individuals; analysis was per-
formed either by restriction enzyme digestion or by SSCP
gel electrophoresis of PCR-amplified genomic DNA.
Northern Blot Analysis
A 489-bp (nt 9488–9976, exons 51–54) fragment of
COH1, amplified by RT-PCR on lymphoblastoid cell
RNA and labeled with [a32P]-dCTP isotope using Redi-
prime II (Amersham Pharmacia), was used as a probe
for northern blot analysis; Nick column (Amersham
Pharmacia) purification was performed after labeling.
Human multiple-tissue northern (MTN) blots I and II
and fetal MTN blots (Clontech) were hybridized in the
presence of herring sperm DNA and human placental
DNA (Sigma). Hybridization was performed at 65C
after prehybridization in ExpressHyb solution (Clon-
tech). Filters were washed in 1 # SSC and 0.5% SDS
solution for 1 h, and x-ray films were developed after
exposure at 80C.
Results
Identification and Characterization of the COH1 Gene
Haplotype data in Finnish patients with Cohen syn-
drome showed that COH1 is located between marker
lociD8S257 andD8S559 (fig. 2A). Assembly of an∼2.2-
Mb sequence contig, including sequencing of a 162-kb
BAC clone (Genosys, clone 476J3), allowed the identi-
fication of candidate transcripts on the basis of their
location (fig. 2B). The full sequence of the region be-
tween STK3 andDORFIN is available on theNovember
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Figure 3 Genomic structure of COH1 and schematic representation of COH1 alternative splicing. A, Genomic structure of COH1. The
COH1 transcript, comprising 14,093 nt, covers an 864-kb genomic region and is transcribed from 62 exons. The alternatively spliced exons
present in ESTs are shown as colored boxes. The exons are shown in scale relative to each other. The lengths of the intronic sequences are in
scale relative to each other but not relative to the exons. B, Schematic representation of alternative splicing of COH1. The longest predicted
transcript (GenBank accession number AY223814) uses exons 8, 17, 28, and 31 and has an ORF of 12,066 bp. Use of exon 28b, instead of
28, results in a transcript (GenBank accession number AY223815) that is 75 bp shorter. Additional variation is predicted from in-frame splicing
of the 204-bp exon 31 present in ESTs but not experimentally verified. The presence of exons 28 and 28b predicts a shorter transcript, with
an ORF of 4,281 bp (GenBank accession number AY223816). Alternative exons 17b and 8b result in ORFs of 2,589 bp (Genbank accession
number AY223817) and 1,236 bp (GenBank accession number AY223818), respectively.
2002 freeze of the Human Genome Browser (UCSC Ge-
nome Bioinformatics). Mutations were defined in Finn-
ish patients within one of these putative transcription
units. This transcript was initially identified from ho-
mology to mouse BAB26477 (GenBank accession num-
ber AK009750). Starting from this sequence, we assem-
bled the full-length COH1 cDNA (GenBank accession
number AY223814) by sequence identification from
databases, by exon prediction, and by RT-PCR. Analysis
of the full COH1 transcript suggested a putative ATG
translation initiation codon at nucleotide 112 of the
COH1 cDNA sequence although no conserved CAAT,
TATA, or Kozak consensus sequences occurred within
the available upstream sequence. The transcription ini-
tiation site of COH1 remains to be determined. The
longest transcript consists of 14,093 bp and is tran-
scribed from 62 exons spanning a genomic region of
∼864 kb (fig. 3A). The corresponding ORF encodes a
protein of 4,022 aa. Comparison of the COH1 cDNA
sequence with the genomic sequence allowed determi-
nation of exon-intron boundaries, all of which carry
consensus acceptor and donor splice sites. The transla-
tion initiation codon is in exon 2.
There is evidence that the COH1 gene is alternatively
spliced (fig. 3B). Overlapping EST sequences suggest
alternative splicing of exons 8, 17, 28, and 31 (e.g.,
AI377522 for alternative exon 8b, BM042444 for al-
ternative exon 17b, BE048857 for alternative exon 28b,
AI809885 for the presence of both exon 28 and exon
28b, and BF767258 for the lack of exon 31). All but
the variant lacking the 204-bp exon 31 were confirmed
by RT-PCR (data not shown). The use of alternative
exons 8b, 17b, or 28 together with 28b would be pre-
dicted to result in truncated forms of COH1, whereas
exons 28, 28b, and 31 are spliced in frame (fig. 3B).
Northern blot analysis, using a cDNA probe (exons
51–54), showed COH1 to be widely expressed (fig. 4)
although there was apparent differential expression of
different transcripts. In fetal brain, lung, liver, and kid-
ney, two transcripts of ∼2 and ∼5 kb were identified.
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Figure 4 Expression pattern of the COH1 gene. COH1 is widely expressed. A 489-bp probe from the coding region of COH1 was used
in human MTN blot analysis (fetal MTN [A], MTN I [B], and MTN II [C]; Clontech). Two isoforms (∼2 and ∼5 kb) were present in all tissues.
Expression of the longest ∼12–14-kb transcript was detectable in prostate, testis, ovary, and colon. A b-actin probe (bottom) was used as a
control for RNA loading.
These transcripts were also seen in all adult tissues an-
alyzed. A larger transcript (∼12–14 kb) was expressed
in prostate, testis, ovary, and colon in the adult. Ex-
pression of COH1 was very low in adult brain tissue.
Identification of COH1 Mutations
We analyzed 27 Finnish patients with Cohen syn-
drome, from 20 families, as well as five non-Finnish
patients. The results are given in table 1 and depicted
in figure 5. Haplotype analysis of the Finnish patients
suggested the existence of several mutations. One hap-
lotype, present in 30/40 (75%) of disease chromosomes
(fig. 2A, boxed haplotypes), was always found to be
associated with a 2-bp (CT) deletion affecting codons
1116 and 1117 (c.3348_3349delCT; fig. 5A) that leads
to protein truncation at codon 1124. The mutation co-
segregated with the disease phenotype in families with
Cohen syndrome. Patients in 11 families (patients 1–15)
were homozygous for this mutation. It was also found
in heterozygous form in eight families (patients 16–26),
in which the patients’ other COH1 chromosome carried
a different haplotype. In only one of these families (pa-
tient 16) was a further putative mutation identified, a
missense substitution (c.6578TrG at codon 2193; fig.
5B) of a neutral leucine to a basic arginine residue. Nei-
ther mutation was found in 58 Finnish or 94 CEPH
control samples. Only one Finnish family (patient 27)
did not carry the most common haplotype and is likely
to be homozygous for a further, as yet unidentified
COH1 mutation.
The seven mutations identified in five non-Finnish pa-
tients with Cohen syndrome (table 1; fig. 5C–5I) are
predicted to result in premature protein truncation. One
Belgian patient (patient 30) was homozygous for an
R2351X mutation in exon 39 (fig. 5C). Two patients,
one British (patient 28) and one Belgian (patient 31)
were compound heterozygotes (table 1; fig. 5D–5G). In
addition, two other protein-truncating mutations were
found in heterozygous form (patients 29 and 32; figs.
5H and 5I). None of the non-Finnish COH1 mutations
identified was found in 94 CEPH controls.
Protein Homologies and Predicted Domains of the
COH1 Protein
Analysis of aa sequence of the predicted COH1 pro-
tein (fig. 6), using ProDom, revealed high similarity
(94%) over aa 2–317 to domain family PD149545 and
revealed moderate similarity (49%; aa 3711–3824) to
domain family PD025730. Both are homologous to Sac-
charomyces cerevisiae vacuolar sorting-associated pro-
tein VPS13. Moreover, a Prosite scan revealed 100%
pattern homologies (aa 3637–3665) to the binding-pro-
tein–dependent transport systems inner membrane com-
ponent signature domain (Higgins et al. 1990) and to
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Table 1
Summary of COH1 Gene Mutations in 32 Patients
MUTATION
EXON
PATIENT
NO.a
NO. OF HOMOZYGOUS/
HETEROZYGOUS PATIENTSDNA Change Protein Change
c.3348_3349delCT C1117F…I1124X 23 1–26 15/11
c.6578TrG L2193R 37 16 0/1
c.4572_4573insA E1525R…E1569X 29 28 0/1
c.EX30delb A1570G…A1573X 30 28 0/1
c.8472GrA W2824X 46 29 0/1
c.7051CrT R2351X 39 30 1/0
c.5426_5427dupAG Q1810S…K1830X 34 31 0/1
c.2193CrT R692X 15 31 0/1
c.6420_6421delGA Q2140H…L2167X 36 32 0/1
a No mutation had been identified in patient 27.
b The genomic basis of c.EX30del remains undefined, because the splice sites and 360 bp
of intronic sequences flanking exon 30 were normal.
the zinc-binding region signature of the neutral zinc me-
tallopeptidases (Jongeneel et al. 1989). A possible vac-
uolar targeting motif (Stack et al. 1995; aa 1518–1521)
was found with the PSORT II program, which also pre-
dicted COH1 to have endoplasmic reticulum (ER)
membrane topology. In addition, TMAP and Kyte-Doo-
little hydrophobicity analysis predicted 10 transmem-
brane domains for COH1 (fig. 6). COH1 contains a
potential ER retention signal (Teasdale and Jackson
1996) at the C-terminus, with a lysine residue at aa 4.
Two peroxisomal matrix protein targeting signal 2
(PTS2) consensus sequences (McNew and Goodman
1996) were found, one close to the N-terminus (aa
263–271) and the other close to the C-terminus (aa
3553–3561).
Protein BLAST alignment of the COH1 sequence
showed cross-species homology to several proteins of un-
known function. In particular, the N- and C-terminal se-
quences (aa 1–85 and 3,639–3,826) were conserved and
shared homology with S. cerevisiaeVPS13 (Q07878) pro-
tein, as well as the CHAC gene underlying choreoacan-
thocytosis (MIM 200150) (Rampoldi et al. 2001; Ueno
et al. 2001). This indicates a possible involvement in con-
trol of trans-Golgi network protein sorting.
Discussion
We have identified a gene, COH1, spanning a genomic
region of 864 kb that is mutated in Cohen syndrome
and encodes a novel protein of unknown function. We
had previously mapped the COH1 locus close to marker
D8S1762 on chromosome 8q22, by linkage and link-
age disequilibrium analysis (Tahvanainen et al. 1994;
Kolehmainen et al. 1997). A historical recombination in
a single disease chromosome in a patient with newly
diagnosed Cohen syndrome (fig. 2A) excluded the region
distal to the DORFIN gene as the site of the causative
mutation, allowing us to focus the search for COH1 in
the region between loci D8S257 and D8S559. We have
now identified a total of nine putative mutations within
the COH1 gene, eight of which are predicted to result
in premature protein truncation. Within the Finnish co-
hort, the mutations identified confirmed our haplotype
analyses and suggested that a number of mutations are
still to be identified. The mutation-detection techniques
employed to date are not 100% sensitive, and, in par-
ticular, large intragenic genomic deletions in compound
heterozygous patients would not have been identified by
the analyses of genomic DNA. This remains an avenue
for future investigation. The nonconservedmissense sub-
stitution observed in one Finnish patient (patient 16;
table 1), was not present in 304 control chromosomes.
However, it remains possible that this is a rare poly-
morphism rather than a pathogenic mutation. All pa-
tients screened had the classical Cohen syndrome phe-
notype, as defined in Finnish families (Kivitie-Kallio and
Norio 2001). All 31 patients with mutations in COH1
(table 1) show a striking clinical similarity, with clinical
homogeneity among Finnish and non-Finnish patients
with Cohen syndrome. Their phenotype includes micro-
cephaly (100%), developmental delay (100%), retinal
dystrophy (100%), neutropenia (100%), joint laxity
(97%; 31/32), and the characteristic dysmorphic ap-
pearance of Cohen syndrome (100%). Mutational stud-
ies will now be required to show the extent to which
the clinical heterogeneity among other reported patients
with Cohen syndrome is explained by allelic or locus
heterogeneity.
Examination of homologous EST sequences shows
that the COH1 gene has a complicated pattern of al-
ternative splicing which potentially leads to the use of
four different termination codons (fig. 3B) and to three
additional in-frame, alternatively spliced forms. In ad-
dition, computational analysis indicates a complex,
multidomain structure for the COH1 protein, implying
that the various COH1 isoforms may have different
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functions within the cell. The functional relevance of
the predicted domains needs to be tested experimentally.
However, on the basis of the domains present and the
identified homologies of the COH1 protein, some func-
tional predictions can be made. The conserved N- and
C-terminal domains share homology to the S. cerevisiae
VPS13 protein. The VPS13 protein in S. cerevisiae is
known to be involved in trafficking of membrane pro-
teins between the trans-Golgi network and the prevac-
uolar compartment (Stack et al. 1995; Redding et al.
1996; Brickner and Fuller 1997). This suggests a role
in intracellular vesicle-mediated sorting and transport
of proteins. The presence of subcellular targeting motifs
may suggest a role in protein sorting at various sub-
cellular locations. COH1 contains two peroxisomal
matrix protein targeting signal 2 (PTS2) consensus se-
quences, which, contrary to known peroxisomal pro-
teins with a PTS2 signal (Erdmann 1994; Braverman et
al. 1997; Purdue et al. 1997), are located in atypical
positions. To our knowledge, the coexistence of ER re-
tention and matrix PTS2 signals has not been previously
described, whereas several peroxisomal membrane pro-
teins have been shown to have overlapping ER-targeting
and peroxisomal membrane–targeting signals, suggest-
ing direct involvement of ER in regulating the sorting
of proteins to peroxisomes (Mullen et al. 1999; Mullen
and Trelease 2000).
High homology of the N- and C-terminal sequences
of COH1 to the relatively large VPS13-like proteins
in eight species (S. cerevisiae, Schizosaccharomyces
pombe, Caenorhabditis elegans, Drosophila melano-
gaster, Arabidopsis thaliana, Anopheles gambiae, Ma-
caca fascicularis, and Dictyostelium discoideum) indi-
cate that the corresponding genes are evolutionarily
related to COH1. A human gene with homologies to
COH1, CHAC (which, when mutated, underlies cho-
reoacanthocytosis [Rampoldi et al. 2001; Ueno et al.
2001]) has been described elsewhere to encode a pro-
tein, chorein, with N- and C-terminal VPS13 domains.
It is perhaps of interest that both Cohen syndrome and
choreoacanthocytosis involve similar organ systems
(psychomotor deficiency and a hematological abnor-
mality); this suggests the intriguing possibility that the
two diseases may share a common pathogenic pathway.
The motifs predicted from the VPS13-like proteins
reveal a variable group of proteins, some of which
display predicted peroxisomal, ER, and vacuolar tar-
geting signals like COH1 (e.g.,D. melanogaster protein
CG32113-PA), whereas some lack these targeting sig-
nals (e.g., human chorein and yeast VPS13).
Identification of the gene underlying Cohen syndrome
will facilitate the early diagnosis of the disorder and
allow the definition of the phenotypic range of the con-
dition. The COH1 protein identified is novel and of
unknown function, and its possible involvement in ves-
icle-mediated sorting and intracellular protein transport
may indicate a family of proteins that includes candi-
dates for other mental retardation syndromes. Future
work must focus on understanding the function of
COH1 and on identifying the pathogenic mechanism
underlying Cohen syndrome.
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reoacanthocytosis)
Poˆle Bio-Informatique Lyonnais, http://npsa-pbil.ibcp.fr/ (for
SOPMA)
Southampton BioInformatics Data Server, http://molbiol.soton
.ac.uk/ (for Align)
TMAP Multiple Sequence Alignment Form, http://www.mbb
.ki.se/tmap/
UCSC Genome Bioinformatics, http://genome.cse.ucsc.edu/ (for
Human Genome Browser)
1368 Am. J. Hum. Genet. 72:1359–1369, 2003
UK Human Genome Mapping Project Resource Centre,
http://www.hgmp.mrc.ac.uk/ (for NIX)
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